⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14749818 | 1.00 | — | — | |
| SCHEMBL19860152 | 1.00 | — | — | |
| SCHEMBL10119789 | 1.00 | — | — | |
| SCHEMBL10110535 | 1.00 | — | — | |
| SCHEMBL16355133 | 0.76 | — | — | |
| SCHEMBL9055528 | 0.74 | — | — | |
| SCHEMBL21325774 | 0.74 | — | — | |
| SCHEMBL22118339 | 0.74 | — | — | |
| SCHEMBL19674836 | 0.74 | — | — | |
| SCHEMBL4965273 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080138300-A2 | COMPOSITION COSMETIQUE COMPRENANT UN POLYMERE ACRYLIQUE | L'OREAL S.A. (FR) | 2008-06-12 | — | — | US | claimed |
| US-20060083696-A1 | Composition cosmetique comprenant un polymere acrylique | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | claimed |
| EP-1647268-A1 | Cosmetic composition comprising an acrylic polymer | L'OREAL (FR) | 2006-04-19 | — | — | EP | claimed |
| WO-2023093832-A1 | TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海济煜医药科技有限公司 | 2023-06-01 | — | — | WO | disclosed |
| CN-114746409-A | CGRP antagonists useful as tracer compounds for positron emission tomography | 伊莱利利公司 | 2022-07-12 | — | — | CN | disclosed |
| WO-2022133037-A1 | MACROCYCLES AND THEIR USE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| US-10696780-B2 | Epoxy resin composition | THREEBOND CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| US-9981960-B2 | Pyrrolidine compound and application as melanocortin receptor agonist | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2018-05-29 | — | — | US | disclosed |
| US-20170369629-A1 | EPOXY RESIN COMPOSITION | THREEBOND CO., LTD. (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170326250-A1 | CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2017-11-16 | — | — | US | disclosed |
| US-20170190697-A1 | NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| EP-0164999-A2 | Film-forming composition containing an antimicrobial agent | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-12-18 | — | — | EP | disclosed |
| US-4395569-A | ESTERIFICATION OF AN ALKANOLAMINE ORGANIC SULFONIC ACID SALT; HEATING | ROHM AND HAAS COMPANY (US) | 1983-07-26 | — | — | US | disclosed |
| US-4194052-A | ESTERIFICATION WITH AN ORGANIC ACID OF A SULFONIC ACID SALT OF AN ALKANOLAMINE, INTERMEDIATES FOR CORRESPONDING ISOCYANATES | ROHM AND HAAS COMPANY (US) | 1980-03-18 | — | — | US | disclosed |
| US-4176232-A | Sulfonic acid salts of acyloxyalkylamines | ROHM AND HAAS COMPANY (US) | 1979-11-27 | — | — | US | disclosed |
| US-4058462-A | System for sustained release of phenolic material from porous granules of insoluble polymeric phenolic complexes | GAF CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
| US-4046744-A | Thermosetting coatings based on ketoxime-blocked isocyanates and oxazolidines | ROHM AND HAAS COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3985540-A | Metal complexes of hydroxyquinoline and polymeric porous granules | GAF CORPORATION (US) | 1976-10-12 | — | — | US | disclosed |
| US-3954682-A | GRANULES OR BEADS | GAF CORPORATION (US) | 1976-05-04 | — | — | US | disclosed |
| US-3939200-A | ISOCYANATE INTERMEDIATES | ROHM AND HAAS COMPANY (US) | 1976-02-17 | — | — | US | disclosed |